Gil Brewer Bibliography Apa

  • Adamson SJ, Sellman JD. Five-year outcomes of alcohol-dependent persons treated with motivational enhancement. Journal of Studies on Alcohol and Drugs. 2008;69:589–593. [PubMed: 18612575]

  • Adamson SJ, Sellman JD, Frampton CM. Patient predictors of alcohol treatment outcome: a systematic review. Journal of Substance Abuse Treatment. 2009;36:75–86. [PubMed: 18657940]

  • Adamson SJ, Heather N, Morton V, et al. Initial preference for drinking goal in the treatment of alcohol problems: II. Treatment outcomes. Alcohol and Alcoholism. 2010;45:136–142. [PubMed: 20130150]

  • Addolorato G, Leggio L, Ferrulli A, et al. Effectiveness and safety of baclofen for maintenance of alcohol abstinence in alcohol-dependent patients with liver cirrhosis: randomised, double-blind controlled study. The Lancet. 2007;370:1915–1922. [PubMed: 18068515]

  • Addolorato G, Leggio L, Ojetti V, et al. Effects of short-term moderate alcohol administration on oxidative stress and nutritional status in healthy males. Appetite. 2008;50:50–56. [PubMed: 17602789]

  • Adelstein AM, Marmot MG, Bulusu L. Migrant studies in Britatin. British Medical Bulletin. 1984;40:315–319. [PubMed: 6398100]

  • Agrawal A, Hinrichs AL, Dunn G, et al. Linkage scan for quantitative traits identifies new regions of interest for substance dependence in the Collaborative Study on the Genetics of Alcoholism (COGA) sample. Drug and Alcohol Dependence. 2008;93:12–20. [PMC free article: PMC2266629] [PubMed: 17942244]

  • AGREE Collaboration. Appraisal of Guidelines for Research and Evaluation (AGREE) Instrument. London: St George's Hospital Medical School; 2001.

  • AGREE Collaboration. Development and validation of an international appraisal instrument for assessing the quality of clinical practice guidelines: the AGREE project. Quality and Safety in Health Care. 2003;12:18–23. [PMC free article: PMC1743672] [PubMed: 12571340]

  • Ahles TA, Schlundt DG, Prue DM, et al. Impact of aftercare arrangements on the maintenance of treatment success in abusive drinkers. Addictive Behaviors. 1983;8:53–58. [PubMed: 6308970]

  • Ahmadi J, Ahmadi N. A double-blind, placebo-controlled study of naltrexone in the treatment of alcohol dependence. German Journal of Psychiatry. 2002;5:85–89.

  • Ahn H, Wampold B. Where oh where are the specific ingredients? A metaanalysis of component studies in counseling and psychotherapy. Journal of Counseling Psychology. 2001;48:251–257.

  • Aira M, Kauhanen J, Larivaara P, et al. Factors influencing inquiry about patients' alcohol consumption by primary health care physicians: qualitative semi-structured interview study. Family Practice. 2003;20:270–275. [PubMed: 12738695]

  • Alcoholics Anonymous. About Us: Membership. 2010. [May 2011]. Available from: http://www​.alcoholics-anonymous​.org.uk/?PageID=54.

  • Alden LE. Behavioral self-management controlled-drinking strategies in a context of secondary prevention. Journal of Consulting and Clinical Psychology. 1988;56:280–286. [PubMed: 3372836]

  • Alessi SM, Hanson T, Wieners M, et al. Low-cost contingency management in community clinics: delivering incentives partially in group therapy. Experimental and Clinical Psychopharmacology. 2007;15:293–300. [PubMed: 17563216]

  • Alexander L. Wernicke's disease. Identity of lesions produced experimentally by B1 avitaminosis in pigeons with hemorhaggic polioencephalitis occurring in chronic alcoholism in man. American Journal of Pathology. 1940;16:61–70. [PMC free article: PMC1965080] [PubMed: 19970486]

  • Alexander JF, Waldron HB, Newberry A, et al. The functional family therapy model, Family Therapy for Adolescent Drug Abuse. Friedman AS, Granick S, editors. Lexington, MA: Lexington Books; 1990. pp. 183–200.

  • Allan C, Smith I, Mellin M. Detoxification from alcohol: a comparison of home detoxification and hospital-based day patient care. Alcohol and Alcoholism. 2000;35:66–69. [PubMed: 10684780]

  • Allen J, Copello A, Orford J. Fear during alcohol detoxification: views from the clients' perspective. Journal of Health Psychology. 2005;10:503–510. [PubMed: 16014388]

  • Allen JP. Assessment of alcohol problems: an overview, Assessing Alcohol Problems: A Guide for Clinicians and Researchers. Allen JP, Wilson WB, editors. Bethesda, MD: National Institute on Alcohol Abuse and Alcoholism; 2003.

  • Allen JP, Wilson VB. Assessing Alcohol Problems: A Guide for Clinicians and Researchers. Bethesda, MD: National Institute on Alcohol Abuse and Alcoholism; 2003.

  • Allen JP, Sillanaukee P, Strid N, et al. Assessing Alcohol Problems: A Guide for Clinicians and Researchers. Allen JP, Wilson VB, editors. Bethesda, MD: National Institute on Alcohol Abuse and Alcoholism; 2003.

  • Allen NB, Chambers R, Knight W. Mindfulness-based psychotherapies: a review of conceptual foundations, empirical evidence and practical considerations. Australian and New Zealand Journal of Psychiatry. 2006;40:285–294. [PubMed: 16620310]

  • Alterman A, Hayashida M, O'Brien CP. Treatment response and safety of ambulatory medical detoxification. Journal of Studies on Alcohol. 1988;49:160–166. [PubMed: 3361908]

  • Altintoprak AE, Zorlu N, Coskunol H, et al. Effectiveness and tolerability of mirtazapine and amitriptyline in alcoholic patients with co-morbid depressive disorder: a randomized, double-blind study. Human Psychopharmacology: Clinical and Experimental. 2008;23:313–319. [PubMed: 18327889]

  • Altman DG, Bland JM. Diagnostic tests 1: sensitivity and specificity. British Medical Journal. 1994;308:1552. [PMC free article: PMC2540489] [PubMed: 8019315]

  • Altman DG, Bland JM. Diagnostic tests 2: predictive values. British Medical Journal. 1994;309:102. [PMC free article: PMC2540558] [PubMed: 8038641]

  • Alwyn T, John B, Hodgson RJ, et al. The addition of a psychological intervention to a home detoxification programme. Alcohol and Alcoholism. 2004;39:536–541. [PubMed: 15466899]

  • American Academy of Child and Adolescent Psychiatry. Practice parameter for the assessment and treatment of children and adolescents with substance use disorders. Journal of the American Academy of Child and Adolescent Psychiatry. 2005;44:609–621. [PubMed: 15908844]

  • Anderson DA, Parker JD. The use of a mental status examination in a chemical dependence treatment program. Journal of Substance Abuse Treatment. 1997;14:377–382. [PubMed: 9368215]

  • Anderson P, Baumberg B. Alcohol in Europe A Report for the European Commission. London: Institute of Alcohol Studies; 2005.

  • Andreasson S, Hansagi H, Österlund B. Short-term treatment for alcohol-related problems: four session guided self change versus one session of advice – a randomized, controlled trial. Addiction. 2002;28:57–62. [PubMed: 12377361]

  • Annemans L, Vanoverbeke N, Tecco J, et al. Economic evaluation of Campral (Acamprosate) compared to placebo in maintaining abstinence in alcohol-dependent patients. European Addiction Research. 2000;6:71–78. [PubMed: 10899732]

  • Annis HA. A relapse prevention model for treatment of alcoholics, Treating Addictive Behaviors Processes of Change. Miller WR, Heather N, editors. New York: Plenum Press; 1986.

  • Annis HM. Inpatient versus outpatient setting effects in alcoholism treatment: revisiting the evidence. Addiction. 1996;91:1804–1807.

  • Anton RF. Naltrexone for the management of alcohol dependence. New England Journal of Medicine. 2008;359:715–721. [PMC free article: PMC2565602] [PubMed: 18703474]

  • Anton RF, Moak DH. Carbohydrate deficient transferrin (CDT) and gamma-glutamyl transferase (GGT) as markers of heavy alcohol consumption: gender differences. Alcoholism: Clinical and Experimental Research. 1994;18:747–754. [PubMed: 7943686]

  • Anton RF, Moak DH, Waid LR, et al. Naltrexone and cognitive behavioral therapy for the treatment of outpatient alcoholics: results of a placebo controlled trial. American Journal of Psychiatry. 1999;156:1758–1764. [PubMed: 10553740]

  • Anton RF, Pettinati H, Zweben A, et al. A multi-site dose ranging study of Nalmefene in the treatment of alcohol dependence. Journal of Clinical Psychopharmacology. 2004;24:421–428. [PubMed: 15232334]

  • Anton RF, Moak DH, Latham P, et al. Naltrexone combined with either cognitive behavioural or motivational enhancement therapy for alcohol dependence. Journal of Clinical Psychopharmacology. 2005;25:349–357. [PubMed: 16012278]

  • Anton RF, O'Malley SS, Ciraulo DA, et al. Combined pharmacotherapies and behavioral interventions for alcohol dependence. The Journal of the American Medical Association. 2006;295:2003–2017. [PubMed: 16670409]

  • Anton RF, Kranzler H, Breder C, et al. A randomized, multicenter, double-blind, placebo-controlled study of the efficacy and safety of aripiprazole for the treatment of alcohol dependence. Journal of Clinical Psychopharmacology. 2008;28:5–12. [PubMed: 18204334]

  • Anton RF, Oroszi G, O'Malley S, et al. An evaluation of μ-opioid receptor (OPRM1) as a predictor of naltrexone response in the treatment of alcohol dependence: results from the Combined Pharmacotherapies and Behavioral Interventions for Alcohol Dependence (COMBINE) study. Archives of General Psychiatry. 2008;65:135–144. [PMC free article: PMC2666924] [PubMed: 18250251]

  • APA. Diagnostic and Statistical Manual of Mental Disorders, 3rd revised (DSM–III–R). Washington, DC: APA; 1987.

  • APA. Diagnostic and Statistical Manual of Mental Disorders, 4th revised (DSM-IV). Washington, DC: APA; 1994.

  • APA. DSM-5 Development: Substance-Related Disorders. Washington, DC: APA; 2010. [5 October 2010]. Available from: www​.dsm5.org/proposedrevisions​/pages/substance--relateddisorders.aspx.

  • Army Individual Test Battery. Manual of Directions and Scoring. Washington, DC: War Department, Adjutant General's Office; 1944.

  • Asplund CA, Aaronson JW, Aaronson HE. 3 regimens for alcohol withdrawal and detoxification. Journal of Family Practice. 2004;53:545–554. [PubMed: 15251094]

  • Babor TF. Reliability of the ethanol dependence syndrome scale. Psychology of Addictive Behaviors. 1996;10:97–103.

  • Babor TF, Higgins-Biddle JC, Saunders JB, et al. AUDIT – The Alcohol Use Disorders Identification Test: Guidelines for Use in Primary Care. 2. Geneva: WHO; 2001.

  • Babor TF, Steinberg K, Zweben A, et al. Treatment effects across multiple dimensions of outcome, Treatment Matching in Alcoholism. Babor TF, Del Boca FK, editors. Cambridge: Cambridge University Press; 2003. pp. 50–165.

  • Bacchus L. Client perceptions of inpatient treatment: a qualitative account with implications for service delivery. Drugs: Education, Prevention and Policy. 1999;6:87–97.

  • Back SE, Brady KT, Sonne SC, et al. Symptom improvement in co-occurring PTSD and alcohol dependence. The Journal of Nervous and Mental Disease. 2006;194:690–696. [PubMed: 16971821]

  • Baekeland F, Lundwell L, Kissin B, et al. Correlates of outcome in disulfiram treatment of alcoholism. The Journal of Nervous and Mental Disease. 1971;153:1–9. [PubMed: 4936190]

  • Bagrel A, d'Houtaud A, Gueguen R, et al. Relations between reported alcohol consumption and certain biological variables in an “unselected” population. Clinical Chemistry. 1979;25:1242–1246. [PubMed: 37002]

  • Bak T, Mioshi E. A cognitive bedside assessment beyond the MMSE: the Addenbrooke's Cognitive Examination. Practical Neurology. 2007;7:245–249. [PubMed: 17636139]

  • Balldin J, Berglund M, Borg S, et al. A 6-month controlled naltrexone study: combined effect with cognitive behavioral therapy in outpatient treatment of alcohol dependence. Alcoholism: Clinical and Experimental Research. 2003;27:1142–1149. [PubMed: 12878920]

  • Baltieri DA, de Andrade AG. Efficacy of acamprosate in the treatment of alcohol-dependent outpatients. Revista Brasileira de Psiquiatria. 2003;25:156–159. [PubMed: 12975689]

  • Baltieri DA, Daró FR, Ribeiro PL, et al. Comparing topiramate with naltrexone in the treatment of alcohol dependence. Addiction. 2008;103:2035–2044. [PubMed: 18855810]

  • Banys P. The clinical use of disulfiram (Antabuse): a review. Journal of Psychoactive Drugs. 1988;20:243–260. [PubMed: 3069984]

  • Barber JP, Crits-Christoph P, Luborsky L. Effects of therapist adherence and competence on patient outcome in brief dynamic therapy. Journal of Consulting and Clinical Psychology. 1996;64:619–622. [PubMed: 8698958]

  • Barber JP, Gallop R, Crits-Christoph P, et al. The role of therapist adherence, therapist competence, and the alliance in predicting outcome of individual drug counseling: Results from the NIDA Collaborative Cocaine Treatment Study. Psychotherapy Research. 2006;16:229–240.

  • Barnaby B, Drummond DC, McCloud A, et al. Substance misuse in psychiatric inpatients: comparison of a screening questionnaire survey with case notes. British Medical Journal. 2003;327:783–784. [PMC free article: PMC214087] [PubMed: 14525876]

  • Barrias JA, Chabac S, Ferreira L, et al. Acamprosate: multicenter Portuguese efficacy and tolerance evaluation study. Psiquiatria Clinica. 1997;18:149–160.

  • Barry KL, Fleming MF. The Alcohol Use Disorders Identification Test (AUDIT) and the SMAST-13 predictive validity in a rural primary care sample. Alcohol. 1993;28:33–42. [PubMed: 8471085]

  • Bart G, Schluger JH, Borg L, et al. Nalmefene induced elevation in serum prolactin in normal human volunteers: partial kappa-opioid agonist activity? Neuropsychopharmacology. 2005;30:2254–2262. [PubMed: 15988468]

  • Bartu A, Saunders W. Domiciliary detoxification: a cost effective alternative to inpatient treatment. Australian Journal of Advanced Nursing. 1994;11:12–18. [PubMed: 7980884]

  • Bates ME, Barry D, Dowden SC. Neurocognitive impairment associated with alcohol use disorders: implications for treatment. Experimental and Clinical Psychopharmacology. 2002;10:193–212. [PubMed: 12233981]

  • Beck AT, Wright FD, Newman CF. Cognitive Therapy of Substance Abuse. New York, NY: Guildford Press; 1993.

  • Beich A, Gannik D, Malterud K. Screening and brief intervention for excessive alcohol use: qualitative interview study of the experiences of general practitioners. British Medical Journal. 2002;325:870–874. [PMC free article: PMC129636] [PubMed: 12386040]

  • Bell DC, Williams ML, Nelson R, et al. An experimental test of retention in residential and outpatient programs. American Journal of Drug and Alcohol Abuse. 1994;20:331–340. [PubMed: 7977218]

  • Bennett-Levy J, Richards DA, Farrand P, editors. The Oxford Guide to Low Intensity CBT Interventions. Oxford: Oxford University Press; 2010.

  • Berglund M. A better widget? Three lessons for improving addiction treatment from a meta-analytical study. Addiction. 2005;100:742–750. [PubMed: 15918803]

  • Berlin JA. Does blinding of readers affect the results of meta-analyses? Lancet. 2001;350:185–186. [PubMed: 9250191]

  • Besson J, Aeby F, Kasas A, et al. Combined efficacy of acamprosate and disulfiram in the treatment of alcoholism: a controlled study. Alcoholism: Clinical and Experimental Research. 1998;22:573–579. [PubMed: 9622434]

  • Beullens J, Aertgeerts B. Screening for alcohol abuse and dependence in older people using DSM criteria: a review. Aging & Mental Health. 2004;8:76–82. [PubMed: 14690871]

  • Bien TH, Miller WR, Tonigan JS. Brief interventions for alcohol problems: a review. Addiction. 1993;88:315–335. [PubMed: 8461850]

  • Bischof G, Grothues J, Reinhardt S, et al. Evaluation of a telephone-based stepped care intervention for alcohol-related disorders: a randomised controlled trial. Drug and Alcohol Dependence. 2008;93:244–251. [PubMed: 18054443]

  • Bischof GH, Richmond CJ, Case AR. Detoxification at home: a brief solution-oriented family systems approach. Contemporary Family Medicine. 2003;25:17–39.

  • Blondell RD. Ambulatory detoxification of patients with alcohol dependence. American Family Physician. 2005;71:495–502. [PubMed: 15712624]

  • Blondell RD, Looney SW, Hottman LM, et al. Characteristics of intoxicated trauma patients. Journal of Addiction Disorders. 2002;21:1–12. [PubMed: 12296497]

  • Boeijinga PH, Parot P, Soufflet L, et al. Pharmacodynamic effects of acamprosate on markers of cerebral function in alcohol-dependent subjects administered as pre-treatment and during alcohol abstinence. Neuropsychobiology. 2004;50:71–77. [PubMed: 15179024]

  • Boland B, Drummond DC, Kaner E. Brief interventions for alcohol use disorders. Advances in Psychiatric Treatment. 2008;14:469–476.

  • Bond GR, McDonel EC. Assertive community treatment and reference groups: an evaluation of their effectiveness for young adults with serious mental illness and substance abuse problems. Psychiatric Rehabilitation Journal. 1991;15:31–43.

  • Book SW, Thomas SE, Randall PK, et al. Paroxetine reduces social anxiety in individuals with a co-occurring alcohol use disorder. Journal of Anxiety Disorders. 2008;22:310–318. [PMC free article: PMC2254554] [PubMed: 17448631]

  • Booth BM, Blow FC. The kindling hypothesis: Further evidence from a U.S. national survey of alcoholic men. Alcohol and Alcoholism. 1993;28:593–598. [PubMed: 8274184]

  • Booth BM, Ludke RL, Wakefield DS, et al. Nonacute inpatient admissions to department of veterans affairs medical centers. Medical Care. 1991;29(Suppl.):AS40–AS50.

  • Booth BM, Blow FC, Ludke RL, et al. Utilization of acute inpatient services for alcohol detoxification. The Journal of Mental Health Administration. 1996;23:366–374. [PubMed: 8965052]

  • Bordin ES. The generalizability of the psychoanalytic concept of the working alliance. Psychotherapy: Theory, Research & Practice. 1979;16:252–260.

  • Bostwick JM, Lapid MI. False positives on the Clinical Institute Withdrawal Assessment for Alcohol – Revised: is this scale appropriate for use in the medically ill? Psychosomatics. 2004;45:256–261. [PubMed: 15123853]

  • Bowden SC. Separating cognitive impairment in neurologically asymptomatic alcoholism from Wernicke-Korsakoff syndrome: is the neuropsychological distinction justified? Psychological Bulletin. 1990;107:355–366. [PubMed: 2190253]

  • Bowen RC, D'Arcya CA, Keegana D. A controlled trial of cognitive behavioral treatment of panic in alcoholic inpatients with comorbid panic disorder. Addictive Behaviors. 2000;25:593–597. [PubMed: 10972451]

  • Bowen S, Witkiewitz K, Dillworth TM, et al. Mindfulness meditation and substance use in an incarcerated population. Psychology of Addictive Behaviors. 2006;20:343–347. [PubMed: 16938074]

  • Bowen S, Witkiewitz K, Dillworth TM, et al. The role of thought suppression in the relationship between mindfulness meditation and alcohol use. Addictive Behaviors. 2007;32:2324–2338. [PMC free article: PMC1989113] [PubMed: 17300875]

  • Bower P, Gilbody S. Stepped care in psychological therapies: access, effectiveness and efficiency. Narrative literature review. British Journal of Psychiatry. 2005;186:11–17. [PubMed: 15630118]

  • Bradizza CM, Stasiewicz PR, Paas ND. Relapse to alcohol and drug use among individuals diagnosed with co-occurring mental health and substance use disorders: A review. Clinical Psychology Review. 2006;26:162–178. [PubMed: 16406196]

  • Brady KT, Myrick H, Henderson S, et al. The use of divalproex in alcohol relapse prevention: a pilot study. Drug and Alcohol Dependence. 2002;67:323–330. [PubMed: 12127203]

  • Brady KT, Sonne S, Anton RF, et al. Sertraline in the treatment of co-occurring alcohol dependence and posttraumatic stress disorder. Alcoholism: Clinical and Experimental Research. 2005;29:395–401. [PubMed: 15770115]

  • Branchey L, Davis W, Lee KK, et al. Psychiatric complications of disulfiram treatment. The American Journal of Psychiatry. 1987;144:1310–1312. [PubMed: 3310670]

  • Brayne C, Best N, Muir M, et al. Five-year incidence and prediction of dementia and cognitive decline in a population sample of women aged 70–79 at baseline. International Journal of Geriatric Psychiatry. 1997;12:1107–1118. [PubMed: 9427095]

  • Breslin FC, Sobell M, Sobell L, et al. Toward a stepped care approach to treating problem drinkers: The predictive utility of within-treatment variables and therapist prognostic ratings. Addiction. 1997;92:1479–1489. [PubMed: 9519491]

  • Breslin FC, Sobell M, Sobell L, et al. Problem drinkers: evaluation of a stepped-care approach. Journal of Substance Abuse. 1999;10:217–232. [PubMed: 10689656]

  • Brewer C. How effective is the standard dose of disulfiram? A review of the alcohol-disulfiram reaction in practice. The British Journal of Psychiatry. 1984;144:200–202. [PubMed: 6704608]

  • British Association of Counselling. Code of Ethics and Practice for Counsellors. Rugby: BAC; 1992.

  • British Medical Association and the Royal Pharmaceutical Society of Great Britain. British National Formulary, 59th edition (BNF 59). London: British Medical Association and the Royal Pharmaceutical Society of Great Britain; 2010.

  • Brosan L, Moore R, Reynolds S. Factors associated with competence in cognitive therapists. Behavioural and Cognitive Psychotherapy. 2007;35:179–190.

  • Brotman MA, Strunk DR, DeRubeis RJ. Therapeutic Alliance and Adherence in Cognitive Therapy for Depression. 2009. In preparation.

  • Brower KJ. Insomnia, alcoholism and relapse. Sleep Medicine Reviews. 2003;7:523–539. [PubMed: 15018094]

  • Brower KJ, Myra Kim H, Strobbe S, et al. A randomized double-blind pilot trial of gabapentin versus placebo to treat alcohol dependence and comorbid insomnia. Alcoholism: Clinical & Experimental Research. 2008;32:1429–1438. [PMC free article: PMC2927959] [PubMed: 18540923]

  • Brown JD. Testing in Language Programs. Upper Saddle River, NJ: Prentice Hall Regents; 1996. pp. 231–294.

  • Brown ME, Anton RF, Malcolm R, et al. Alcohol detoxification and withdrawal seizures: clinical support for kindling hypothesis. Biological Psychiatry. 1988;23:507–514. [PubMed: 3345323]

  • Brown S, McGue M, Maggs J, et al. A developmental perspective on alcohol and youths 16 to 20 years of age. Pediatrics. 2008;121(Suppl. 4):S290–S310. [PMC free article: PMC2765460] [PubMed: 18381495]

  • Brown SA, Inaba RK, Gillin JC, et al. Alcoholism and affective disorder: clinical course of depressive symptoms. American Journal of Psychiatry. 1995;152:45–52. [PubMed: 7802119]

  • Brown SA, Meyer MG, Lippke L, et al. Psychometric evaluation of the customary drinking and drug use record (CDDR): a measure of adolescent alcohol and drug involvement. Journal of Studies on Alcohol. 1998;59:427–438. [PubMed: 9647425]

  • Brown TG, Seraganian P, Tremblay J, et al. Process and outcome changes with relapse prevention versus 12-step aftercare programs for substance abusers. Addiction. 2002;97:677–689. [PubMed: 12084137]

  • Bryant MJ, Simons AD, Thase ME. Therapist skill and patient variables in homework compliance: controlling an uncontrolled variable in cognitive therapy outcome research. Cognitive Therapy and Research. 1999;23:381–399.

  • Bucholz KK, Cadoret R, Cloninger CR, et al. Semi-structured psychiatric interview for use in genetic linkage studies: a report on the reliability for the SSAGA. Journal of Studies on Alcohol. 1994;55:149–158. [PubMed: 8189735]

  • Bullock M, Umen A, Culliton P, et al. Acupuncture treatment of alcoholic recidivism: a pilot study. Alcoholism: Clinical and Experimental Research. 1987;11:292–295. [PubMed: 3307496]

  • Bullock M, Culliton P, Olander R. Controlled trial of acupuncture for severe recidivist alcoholism. Lancet. 1989;1(June):1435–1439. [PubMed: 2567439]

  • Bullock ML, Kiresuk TJ, Sherman RE, et al. A large randomized placebo controlled study of auricular acupuncture for alcohol dependence. Journal of Substance Abuse Treatment. 2002;22:71–77. [PubMed: 11932132]

  • Burman S. The challenge of sobriety: natural recovery without treatment and self-help groups. Journal of Substance Abuse. 1997;9:41–61. [PubMed: 9494938]

  • Burns DD, Nolen-Hoeksema S. Therapeutic empathy and homework compliance in cognitive-behavioral therapy. Journal of Consulting and Clinical Psychology. 1992;60:441–449. [PubMed: 1619098]

  • Burtscheidt W, Wolwer W, Schwarz R, et al. Out-patient behaviour therapy in alcoholism: treatment outcome after 2 years. Acta Psychiatrica Scandinavica. 2001;106:227–232. [PubMed: 12197862]

  • Burtscheidt W, Wolwer W, Schwarz R, et al. Out-patient behaviour therapy in alcoholism: treatment outcome after 2 years. Acta Psychiatrica Scandinavica. 2002;106:227–232. [PubMed: 12197862]

  • Bush K, Kivlahan DR, McDonell MB, et al. The AUDIT alcohol consumption questions (AUDIT-C): an effective brief screening test for problem drinking. Archives of Internal Medicine. 1998;158:1789–1795. [PubMed: 9738608]

  • Busto U, Simpkins J, Sellers EM, et al. Objective determination of benzodiazepine use and abuse in alcoholics. British Journal of Addiction. 1983;78:429–435. [PubMed: 6140937]

  • Butterworth RF. Effects of thiamine deficiency on brain metabolism: implications for the pathogenesis of the Wernicke-Korsakoff syndrome. Alcohol and Alcoholism. 1989;24:271–279. [PubMed: 2675860]

  • Cahill J, Barkham M, Hardy G, et al. Outcomes of patients completing and not completing cognitive therapy for depression. British Journal of Clinical Psychology. 2003;42:133–143. [PubMed: 12828803]

  • Campbell NC, Murray E, Darbyshire J, et al. Desigining and evaluating complex interventions to improve health care. British Medical Journal. 2007;334:455–459. [PMC free article: PMC1808182] [PubMed: 17332585]

  • Caldwell DM, Ades AE, Higgins JP. Simultaneous comparison of multiple treatments: combining direct and indirect evidence. British Medical Journal. 2005;331:897–900. [PMC free article: PMC1255806] [PubMed: 16223826]

  • Carroll KM, Rounsaville BJ, Bryant KJ. Alcoholism in treatment seeking cocaine abusers: Clinical and prognostic significance. Journal of Studies on Alcohol. 1993;54:199–208. [PubMed: 8459714]

  • Carroll K, Nich C, Ball S, et al. Treatment of cocaine and alcohol dependence with psychotherapy and disulfiram. Addiction. 1998;93:713–728. [PubMed: 9692270]

  • Carroll K, Nich C, Ball S, et al. One-year follow-up of disulfiram and psychotherapy for cocaine-alcohol users: sustained effects of treatment. Addiction. 2000;95:1335–1349. [PubMed: 11048353]

  • Carroll KM, Fenton LR, Ball SA, et al. Efficacy of disulfiram and cognitive behavior therapy in cocaine-dependent outpatients: a randomized placebo-controlled trial. Archives of General Psychiatry. 2004;61:264–272. [PMC free article: PMC3675448] [PubMed: 14993114]

  • Casswell S, Thamarangsi T. Reducing harm from alcohol: call to action. The Lancet. 2009;373:2247–2257. [PubMed: 19560606]

  • Chapman PLH, Huygens I. An evaluation of three treatment programmes for alcoholism: an experimental study with 6- and 18-month follow-ups. British Journal of Addiction. 1988;83:67–81. [PubMed: 3345384]

  • Charney AA, Paraherakis AM, Gill KJ. Integrated treatment of comorbid depression and substance use disorders. Journal of Clinical Psychiatry. 2001;62:672–677. [PubMed: 11681761]

  • Cheeta S, Drummond C, Oyefeso A, et al. Low identification of alcohol use disorders in general practice in England. Addiction. 2008;103:766–773. [PubMed: 18412755]

  • Chick J. Safety issues concerning the use of disulfiram in treating alcohol dependence. Drug Safety. 1999;20:427–435. [PubMed: 10348093]

  • Chick J, Ritson B, Connaughton J, et al. Advice versus extended treatment for alcoholism: A controlled study. British Journal of Addiction. 1988;83:159–170. [PubMed: 3345393]

  • Chick J, Gough K, Falkowski W, et al. Disulfiram treatment of alcoholism. British Journal of Psychiatry. 1992;161:84–89. [PubMed: 1638335]

  • Chick J, Howlett H, Morgan MY, et al. United Kingdom multicentre acamprosate study (UKMAS): A 6-month prospective study of acamprosate versus placebo in preventing relapse after withdrawal from alcohol. Alcohol and Alcoholism. 2000;35:176–187. [PubMed: 10787394]

  • Chick J, Anton R, Checinski K, et al. A multicentre, randomized, double-blind, placebo-controlled trial of naltrexone in the treatment of alcohol dependence or abuse. Alcohol and Alcoholism. 2000;35:587–593. [PubMed: 11093966]

  • Chiesa A. Vipassana meditation: systermatic review of current evidence. Journal of Alternative and Complementary Medicine. 2010;16:37–46. [PubMed: 20055558]

  • Cho SH, Wang WW. Acupuncture for alcohol dependence: a systematic review. Alcoholism: Clinical and Experimental Research. 2009;33:1305–1313. [PubMed: 19413653]

  • Choudry N. Medical treatment for problem drug takers, Treating Drug Abusers. Bennett G, editor. London: Routledge; 1990.

  • Christiansen BA, Smith GT, Roehling PV, et al. Using alcohol expectancies to predict adolescent drinking behavior after one year. Journal of Consulting and Clinical Psychology. 1989;57:93–99. [PubMed: 2925979]

  • Christo G, Spurrell S, Alcorn R. Validation of the Christo Inventory for Substance-misuse Services (CISS): a simple outcome evaluation tool. Drug and Alcohol Dependence. 2000;59:189–197. [PubMed: 10891633]

  • Chung T, Colby N, Barnett D, et al. Screening adolescents for problem drinking and performance of brief screens against DSM–IV alcohol diagnoses. Journal of Studies on Alcohol. 2000;61:579–587. [PubMed: 10928728]

  • Chung T, Martin CS, Winters KC, et al. Assessment of alcohol tolerance in adolescents. Journal of Studies on Alcohol. 2001;62:687–695. [PubMed: 11702808]

  • Chutuape MA, Katz EC, Stitzer ML. Methods for enhancing transition of substance dependence patients from inpatient to outpatient treatment. Drug and Alcohol Dependence. 2001;61:137–143. [PubMed: 11137278]

  • Cicerone KD, Dahlberg C, Malec JF, et al. Evidence-based cognitive rehabilitation: updated review of the literature from 1998 through 2002. Archives of Physical Medicine and Rehabilitation. 2005;86:1681–1692. [PubMed: 16084827]

  • Ciraulo DA, Sands BF, Shader RI. Critical review of liability for benzodiazepine abuse among alcoholics. The American Journal of Psychiatry. 1988;145:1501–1506. [PubMed: 2904227]

  • Clark DB, Lesnick L, Hegedus AM. Traumas and other adverse life events in adolescents with alcohol abuse and dependence. Journal of the American Academy of Child and Adolescent Psychiatry. 1997;36:1744–1751. [PubMed: 9401336]

  • Clark DB, Pollock N, Bukstein OG, et al. Gender and comorbid psychopathology in adolescents with alcohol dependence. Journal of the American Academy of Child and Adolescent Psychiatry. 1997;36:1195–1203. [PubMed: 9291720]

  • Clark DB, Lynch KG, Donovan JE, et al. Health problems in adolescents with alcohol use disorders: self-report, liver injury, and physical examination findings and correlates. Alcoholism: Clinical and Experimental Research. 2001;25:1350–1359. [PubMed: 11584156]

  • Clark DB, De Bellis MD, Lynch KG, et al. Physical and sexual abuse, depression and alcohol use disorders in adolescents: onsets and outcomes. Drugs and Alcohol Dependence. 2003;69:51–60. [PubMed: 12536066]

  • Clark DM, Layard R, Smithies R, et al. Improving access to psychological therapy: initial evaluation of two UK demonstration sites. Behaviour Research and Therapy. 2009;47:910–920. [PMC free article: PMC3111658] [PubMed: 19647230]

  • Cloninger CR, Bohman M, Sigvardsson S. Inheritance of alcohol abuse. cross-fostering analysis of adopted men. Archives of General Psychiatry. 1981;38:861–868. [PubMed: 7259422]

  • Cochrane Collaboration. Review Manager (RevMan) [Computer program] Version 427 for Windows. Oxford: The Cochrane Collaboration; 2004.

  • Cochrane M, Cochrane A, Jauhar P, et al. Acetylcholinesterase inhibitors for the treatment of Wernicke-Korsakoff syndrome- three further cases show response to donepezil. Alcohol and Alcoholism. 2005;40:151–144. [PubMed: 15596427]

  • Coffey T. The process of teaching alcohol and opiod withdrawal management strategies to nursing staff in a new medical center. Journal of Addictions Nursing. 1996;8:29–35.

  • Colby SM, Monti P, Barnett N, et al. Brief motivational interviewing in a hospital setting for adolescent smoking: a preliminary study. Journal of Consulting and Clinical Psychology. 1998;66:574–578. [PubMed: 9642898]

  • Collins MN, Burns T, van den Berk PAH, et al. A structured programme for outpatient alcohol detoxification. British Journal of Psychiatry. 1990;156:871–874. [PubMed: 2207519]

  • Connors G, Carroll K, DiClemente C, et al. The therapeutic alliance and its relationship to alcoholism treatment participation and outcome. Journal of Consulting and Clinical Psychology. 1997;65:588–598. [PubMed: 9256560]

  • Connors GJ, Walitzer KS. Reducing alcohol consumption among heavily drinking women: evaluating the contributions of life-skills training and booster sessions. Journal of Consulting and Clinical Psychology. 2001;69:447–456. [PubMed: 11495174]

  • Conrad KJ, Hultman CI, Pope AR, et al. Case managed residential care for homeless addicted veterans: results of a true experiment. Medical Care. 1998;36:40–53. [PubMed: 9431330]

  • Conrod PJ, Stewart SH, Pihl RO, et al. Efficacy of brief coping skills interventions that match different personality profiles of female substance abusers. Psychology of Addictive Behaviours. 2000;14:231–242. [PubMed: 10998949]

  • Cook CCH. Aetiology of alcohol misuse, Seminars in Alcohol and Drug Misuse. Chick J, Cantwell R, editors. London: Gaskell; 1994.

  • Cook CCH. Prevention and treatment of Wernicke-Korsakoff syndrome. Alcohol and Alcoholism. 2000;35(Suppl. 1):19–20. [PubMed: 11304070]

  • Cook CCH, Hallwood PM, Thomson AD. B vitamin deficiency and neuropsychiatric syndromes in alcohol misuse. Alcohol and Alcoholism. 1998;33:317–336. [PubMed: 9719389]

  • Cook P. Social costs of drinking. In: Assland OG, editor. Expert Meeting on the Negative Social Consequences of Alcohol Use; 27–31 August 1990; Oslo: Norwegian Ministry of Health and Social Affairs; 1990. pp. 49–94.

  • Cooney NL, Kadden RM, Litt MD, et al. Matching alcoholics to coping skills or interactional therapies: two year follow up results. Journal of Consulting and Clinical Psychology. 1991;59:598–601. [PubMed: 1655847]

  • Cooper DB. Alcohol Dome detoxification and Assessment. Oxford: Radcliffe Medical Press; 1994.

  • Copeland J. A qualitative study of barriers to formal treatment among women who self-managed change in addictive behaviours. Journal of Substance Abuse Treatment. 1997;14:183–190. [PubMed: 9258863]

  • Copello A, Orford J, Hodgson R, et al. Social behaviour and network therapy: basic principles and early experiences. Addictive Behavior. 2002;27:345–366. [PubMed: 12118625]

  • Copello AG, Velleman RD, Templeton LJ. Family interventions in the treatment of alcohol and drug problems. Drug and Alcohol Review. 2005;24:369–385. [PubMed: 16234133]

  • Copello AG, Templeton L, Velleman R. Family interventions for drug and alcohol misuse: is there a best practice? Current Opinion in Psychiatry. 2006;19:271–276. [PubMed: 16612212]

  • Copello AG, Templeton L, Orford J, et al. The relative efficacy of two levels of a primary care intervention for family members affected by the addiction problem of a close relative: a randomized trial. Addiction. 2009;104:49–58. [PubMed: 19133888]

  • Cornelius JR, Salloum IM, Thase ME, et al. Fluoxetine versus placebo in depressed alcoholic cocaine abusers. Psychopharmacology Bulletin. 1998;34:117–121. [PubMed: 9564208]

  • Coulthard M, Farrell M, Singleton N, Meltzer H. Tobacco, Alcohol and Drug Use and Mental Health. The Office for National Statistics, London: The Stationary Office; 2002.

  • Coulton S, Drummond C, James D, et al. Opportunistic screening for alcohol use disorders in primary care: comparative study. British Medical Journal. 2006;332:511–517. [PMC free article: PMC1388125] [PubMed: 16488896]

  • Cousins MS, Roberts DC, de Wit H. GABA(B) receptor agonists for the treatment of drug addiction: a review of recent findings. Drug and Alcohol Dependence. 2002;65:209–220. [PubMed: 11841892]

  • Cox GB, Walker DR, Freng SA, et al. Outcome of a controlled trial of the effectiveness of intensive case management for chronic public inebriates. Journal of Studies on Alcohol. 1998;59:523–532. [PubMed: 9718104]

  • Cox WM, Klinger E, editors. Handbook of Motivational Counseling: Concepts, Approaches, and Assessment. New York, NY: John Wiley & Sons; 2004.

  • Craig R, Mindell J, Hirani V. Health Survey for England 2008. Volume 1: Physical Activity and Fitness. London: NHS Information Centre; 2009.

  • Crum RM, Anthony JC, Bassett SS, et al. Population-based norms for the Mini-Mental State Examination by age and educational level. Journal of American Medical Association. 1993;269:2386–2391. [PubMed: 8479064]

  • Cummings JL. Mini-Mental State Examination: norms, normals and numbers. Journal of American Medical Association. 1993;269:2420–2421. [PubMed: 8479071]

  • Currie SR, Clark S, Hodgins DC, et al. Randomized controlled trial of brief cognitive–behavioural interventions for insomnia in recovering alcoholics. Addiction. 2004;99:1121–1132. [PubMed: 15317632]

  • Curtis L. Unit Costs of Health and Social Care. Canterbury: Personal Social Services Research Unit, University of Kent; 2009.

  • Curtis JR, Geller G, Stokes EJ, et al. Characteristics, diagnosis and treatment of alcoholism in elderly patients. Journal of the American Geriatric Society. 1989;37:310–316. [PubMed: 2921452]

  • Daeppen JB, Gache P, Landry U, et al. Symptom-triggered vs fixed-schedule doses of benzodiazepine for alcohol withdrawal: a randomized treatment trial. Archives of Internal Medicine. 2002;162:1117–1121. [PubMed: 12020181]

  • Dakof GA, Tejeda M, Liddle HA. Predictors of engagement in adolescent drug abuse treatment. Journal of the American Academy of Child & Adolescent Psychiatry. 2001;40:274–281. [PubMed: 11288768]

  • Dansky BS, Brewerton TD, Kilpatrick DG. Comorbidity of bulimia nervosa and alcohol use disorders: results from the National Women's Study. International Journal of Eating Disorders. 2000;27:180–190. [PubMed: 10657891]

  • Dar K. Alcohol use disorders in elderly people: fact or fiction? Advances in Psychiatric Treatment. 2006;12:173–181.

  • Davidson D, Gulliver SB, Longabaugh R, et al. Building better cognitive-behavioral therapy: is broad-spectrum treatment more effective than motivational enhancement therapy for alcohol-dependent patients treated with naltrexones? Journal of Studies on Alcohol and Drugs. 2007;68:238–247. [PubMed: 17286342]

  • Davidson K, Scott J, Schmidt U, et al. Therapist competence and clinical outcome in the prevention of parasuicide by manual assisted cognitive behaviour therapy trial: the POPMACT study. Psychological Medicine. 2004;34:855–863. [PubMed: 15500306]

  • Davis L, Uezato A, Newell J, et al. Major depression and comorbid substance use disorders. Current Opinion in Psychiatry. 2008;21:14–18. [PubMed: 18281835]

  • Davis WT, Campbell L, Tax J, et al. A trial of “standard” outpatient alcoholism treatment vs. a minimal treatment control. Journal of Substance Abuse Treatment. 2002;23:9–19. [PubMed: 12127464]

  • Davison GC. Stepped care: doing more with less? Journal of Consulting and Clinical Psychology. 2000;68:580–585. [PubMed: 10965633]

  • Dawe S, Rees VW, Mattick R, et al. Efficacy of moderation-orientated cue exposure for problem drinkers: a randomized controlled trial. Journal of Consulting and Clinical Psychology. 2002;70:1045–1050. [PubMed: 12182268]

  • Dawson DA, Grant BF, Stinson FS, et al. Recovery from DSM–IV alcohol dependence: United States, 2001–2002. Addiction. 2005;100:281–292. [PubMed: 15733237]

  • Dawson DA, Grant BF, Stinson FS. The AUDIT-C: screening for alcohol use disorders and risk drinking in the presence of other psychiatric disorders. Comprehensive Psychiatry. 2005;46:405–416. [PubMed: 16275207]

  • Dawson DA, Grant BF, Chou SP, et al. The impact of partner alcohol problems on women's physical and mental health. Journal of Studies on Alcohol and Drugs. 2007;68:66–75. [PubMed: 17149519]

  • Dawson DA, Goldstein RB, Chou PS, et al. Age at first drink and the first incidence of adult-onset DSM–IV alcohol use disorders. Alcoholism: Clinical and Experimental Research. 2008;32:2149–2160. [PMC free article: PMC2760820] [PubMed: 18828796]

  • Day E, Ison J, Keaney F, et al. A National Survey of Inpatient Drug Treatment Services in England. London: National Treatment Agency for Substance Misuse; 2005.

  • Day EJ, Patel J, Georgiou G. Evaluation of a symptom-triggered front-loading 27 detoxification technique for alcohol dependence: a pilot study. Psychiatric Bulletin. 2004;28:407–410.

  • DeCaroulis DD, Rice KL, Ho L, et al. Symptom-driven lorazepam protocol for treatment of severe alcohol withdrawal delirium in the intensive care unit. Pharmacotherapy. 2007;27:510–518. [PubMed: 17381377]

  • Adams JF. Impact of parent training on family functioning. Child and Family Behavior Therapy. 2001;23:29–42.

  • Adshead G. Three degrees of security: attachment and forensic institutions. Criminal Behaviour and Mental Health. 2002;12:S31–S45. [PubMed: 12459809]

  • AGREE Collaboration. Development and validation of an international appraisal instrument for assessing the quality of clinical practice guidelines: the AGREE project. Quality and Safety in Health Care. 2003;12:18–23. [PMC free article: PMC1743672] [PubMed: 12571340]

  • Alemi F, Taxman F, Baghi H, et al. Costs and benefits of combining probation and substance abuse treatment. Journal of Mental Health Policy and Economics. 2006;9:57–70. [PubMed: 17007484]

  • Alexander JF, Parsons BV. Short-term behavioral intervention with delinquent families: impact on family process and recidivism. Journal of Abnormal Psychology. 1973;81:219–225. [PubMed: 4710043]

  • American Academy of Psychiatry and the Law. Ethics Guidelines for the Practice of Forensic Psychiatry. 2005. [accessed June 2008]. Available at: https://www​.aapl.org/pdf/ETHICSGDLNS.pdf.

  • Andrews DA, Bonta J. The Level of Service Inventory-Revised. Toronto: Multi-Health Systems; 1995.

  • Anonymous. On the receiving end. Human Givens: Radical Psychology Today. 2001;8:17–21.

  • Aos S, Lieb R, Mayfield J, et al. Benefits and Costs of Prevention and Early Intervention Programs for Youth. Olympia: Washington State Institute for Public Policy; 2004.

  • APA. Diagnostic and Statistical Manual of Mental Disorders. Washington, DC: APA; 1952.

  • APA. Diagnostic and Statistical Manual of Mental Disorders. 2nd edition. Washington, DC: APA; 1968.

  • APA. Diagnostic and Statistical Manual of Mental Disorders. 3rd edition. Washington, DC: APA; 1980.

  • APA. Diagnostic and Statistical Manual of Mental Disorders: DSM-III-R, 3rd edition, Revised. Washington, DC: APA; 1987.

  • APA. Diagnostic and Statistical Manual of Mental Disorders, 4th edition. Washington, DC: APA; 1994.

  • APA. Diagnostic and Statistical Manual of Mental Disorders: Text Revision (DSM-IV-TR). Washington, DC: APA; 2000.

  • Appelbaum PS. A theory of ethics for forensic psychiatry. Journal of the American Academy of Psychiatry and the Law. 1997;25:233–247. [PubMed: 9323651]

  • Appleby L, Shaw J, Kapur N, et al. Avoidable deaths: five year report by the National Confidential Inquiry into Suicide and Homicide by People with Mental Illness. 2006. [Accessed 30 June 2008]. Available at: http://www​.medicine.manchester​.ac.uk/suicideprevention​/nci/Useful​/avoidable_deaths_full_report.pdf.

  • Armstrong TA. The effect of moral reconation therapy on the recidivism of youthful offenders: a randomized experiment. Criminal Justice and Behaviour. 2003;30:668–687.

  • Austin J, Robinson B, Elms B, et al. The evaluation of two models of treating sentenced federal drug offenders in the community. International Journal of Offender Rehabilitation and Comparative Criminology. 1997;36:247–262.

  • Azrin NH, Donohue B, Teichner GA, et al. A controlled evaluation and description of individual-cognitive problem solving and family-behavior therapies in dually-diagnosed conduct disordered and substance-dependent youth. Journal of Child and Adolescent Substance Abuse. 2001;11:1–43.

  • Babinski LM, Hartsough CS, Lambert NM. Childhood conduct problems, hyperactivity-impulsivity, and inattention as predictors of adult criminal activity. Journal of Child Psychiatry. 1999;40:347–355. [PubMed: 10190336]

  • Baker E, Crichton J. Ex parte A: psychopathy, treatability and the law. Journal of Forensic Psychiatry. 1995;6:101–109.

  • Bandura A. Social cognitive theory: an agentic perspective. Annual Review of Psychology. 2001;52:1–26. [PubMed: 11148297]

  • Bank L, Hicks Marlowe J, Reid JB, et al. A comparative evaluation of parent-training interventions for families of chronic delinquents. Journal of Abnormal Child Psychology. 1991;19:15–33. [PubMed: 2030245]

  • Barkley RA, Shelton TL, Crosswait C, et al. Multi-method psychoeducation intervention for preschool children with disruptive behavior: preliminary results at post-treatment. Journal of Child Psychology and Psychiatry. 2000;41:319–332. [PubMed: 10784079]

  • Barlow J, Stewart-Brown S. Behavior problems and group-based parent education programs. Journal of Developmental and Behavioral Pediatrics. 2000;21:356–370. [PubMed: 11064964]

  • Barlow J, Parsons J, Stewart-Brown S. Preventing emotional and behavioural problems: the effectiveness of parenting programmes with children less than 3 years of age. Child: Care, Health and Development. 2005;31:33–42. [PubMed: 15658964]

  • Barnes J, Ball M, Meadows P, et al. Nurse-Family Partnership Programme: First Year Pilot Sites Implementation in England Pregnancy and the Post-partum Period. London: Department of Children, Schools and Families; 2008.

  • Barnoski R. Outcome Evaluation of Washington State’s Research-based Programs for Juvenile Offenders. Washington, WA: Washington State Institute for Public Policy; 2004.

  • Barratt ES, Stanford M, Felthouse AR, et al. The effects of phenytoin on impulsive and premeditated aggression: a controlled study. Journal of Clinical Psychopharmacology. 1997;17:341–349. [PubMed: 9315984]

  • Barrett B, Byford S, Seivewright H, et al. Service costs for severe personality disorder at a special hospital. Criminal Behaviour and Mental Health. 2005;15:184–190. [PubMed: 16575796]

  • Barrett B, Byford S, Chitsabesan P, et al. Mental health provision for young offenders: service use and cost. British Journal of Psychiatry. 2006;188:541–546. [PubMed: 16738344]

  • Barrett P, Turner C, Rombouts S, et al. Reciprocal skills training in the treatment of externalising behaviour disorders in childhood: a preliminary investigation. Behaviour Change. 2000;17:221–234.

  • Beck R, Fernandez E. Cognitive behavioral therapy in the treatment of anger: a meta-analysis. Cognitive Therapy and Research. 1998;22:63–74.

  • Behan J, Fitzpatrick C, Sharry J, et al. Evaluation of the parenting plus programme. The Irish Journal of Psychology. 2001;22:238–256.

  • Belsky J. Development risks (still) association with early child care. Journal of Child Psychology and Psychiatry. 2001;42:845–859. [PubMed: 11693581]

  • Belsky J, Melhuish E, Barnes J, et al. Effects of Sure Start local programmes on children and families: early findings from a quasi-experimental, cross sectional study. British Medical Journal. 2006;332:1476. [PMC free article: PMC1482335] [PubMed: 16782721]

  • Belsky J, Vandell D, Burchinal M, et al. Are there long term effects of early child care? Child Development. 2007;78:681–701. [PubMed: 17381797]

  • Benjamin LS. Interpersonal Diagnosis and Treatment of Personality Disorders. New York: Guilford; 1993.

  • Benjamin LS. Interpersonal Diagnosis and Treatment of Personality Disorders. 2nd edition. New York: Guilford; 1996.

  • Berlin JA. Does blinding of readers affect the results of meta-analyses? Lancet. 2001;350:185–186. [PubMed: 9250191]

  • Biederman J, Faraone SV, Milberger S, et al. Is childhood oppositional defiant disorder a precursor to adolescent conduct disorder? Findings from a four-year follow-up study of children with ADHD. Journal of American Academy of Child and Adolescent Psychiatry. 1996;35:1193–1204. [PubMed: 8824063]

  • Black DW, Baumgard CH, Bell SE. A 16 to 45 year follow-up of 71 men with antisocial personality disorder. Comprehensive Psychiatry. 1995;36:130–140. [PubMed: 7758299]

  • Black DW, Baumgard CH, Bell SE, et al. Death rates in 71 men with antisocial personality disorder: a comparison with general population mortality. Psychosomatics. 1996;37:131–136. [PubMed: 8742541]

  • Blackburn R. Personality disorder and antisocial deviance: comments on the debate on the structure of the Psychopathy Checklist-Revised. Journal of Personality Disorders. 2007;21:142–159. [PubMed: 17492918]

  • Blackburn R, Coid JC. Empirical clusters of DSM-III personality disorders in violent offenders. Journal of Personality Disorders. 1999;13:18–34. [PubMed: 10228924]

  • Blackburn R, Logan C, Donnelly J, et al. Personality disorder, psychopathy, and other mental disorders: co-morbidity among patients at English and Scottish high security hospitals. Journal of Forensic Psychiatry and Psychology. 2003;14:111–137.

  • Blair RJR, Peschardt KS, Budhani S, et al. The development of psychopathy. Journal of Child Psychology and Psychiatry and Allied Disciplines. 2006;47:262–275. [PubMed: 16492259]

  • Bodenmann G, Cina A, Ledermann T, et al. The efficacy of the Triple P -Positive Parenting Program in improving parenting and child behavior: a comparison with two other treatment conditions. Behaviour Research and Therapy. 2008;46:411–427. [PubMed: 18313033]

  • Bor W, McGee TR, Fagan AA. Early risk factors for adolescent antisocial behaviour: an Australian longitudinal study. Australian and New Zealand Journal of Psychiatry. 2004;38:365–372. [PubMed: 15144516]

  • Borduin C, Schaeffer C. Multisystemic treatment of juvenile sexual offenders: a progress report. Journal of Psychology and Human Sexuality. 2001;13:25–42.

  • Borduin CM, Mann BJ, Cone LT, et al. Multisystemic treatment of serious juvenile offenders: long term prevention of criminality and violence. Journal of Consulting and Clinical Psychology. 1995;63:569–578. [PubMed: 7673534]

  • Bowden-Jones O, Iqbal MZ, Tyrer P, et al. Prevalence of personality disorder in alcohol and drug services and associated comorbidity. Addictions. 2004;99:1306–1314. [PubMed: 15369569]

  • Bowers L. Dangerous and Severe Personality Disorder: Response and Role of the Psychiatric Team. London: Routledge; 2002.

  • Bowers L, Carr-Walker P, Paton J, et al. Changes in attitudes to personality on a DSPD unit. Criminal Behaviour and Mental Health. 2005;15:171–183. [PubMed: 16575795]

  • Bowers L, Carr-Walker P, Allan T, et al. Attitude to personality disorder among prison officers working in a dangerous and severe personality disorder unit. International Journal of Law and Psychiatry. 2006;29:333–342. [PubMed: 16764929]

  • Bradley SJ, Jadaa DA, Brody J. Brief psychoeducational parenting program: an evaluation and 1-year follow-up. Journal of the American Academy of Child and Adolescent Psychiatry. 2003;42:1171–1178. [PubMed: 14560166]

  • Brand S, Price R. The Economic and Social Costs of Crime, Home Office Research Study 217. London: Home Office, Research, Development and Statistics Directorate; 2000.

  • Brooks-Gunn J, McCarton CM, Casey PH, et al. Early intervention in low-birth-weight premature infants. Results through age 5 years from the infant health and development program. Journal of the American Medical Association. 1994;272:1257–1262. [PubMed: 7933370]

  • Brooner RK, Kidorf MS, King VL, et al. Preliminary evidence of good treatment response in antisocial drug abusers. Drug and Alcohol Dependence. 1998;49:249–260. [PubMed: 9571389]

  • Buckner JC, Trickett EJ, Corse SJ. Primary Prevention in Mental Health: an Annotated Bibliography. Washington, D C: US Government Printing Office; 1985.

  • Buffington-Vollum J, Edens JF, Johnson DW, et al. Psychopathy as a predictor of institutional misbehaviour among sex offenders: a prospective replication. Criminal Justice and Behavior. 2002;29:497–511.

  • Cadoret RJ, Yates WR, Troughton E, et al. Genetic-environmental interaction in the genesis of aggressivity and conduct disorders. Archives of General Psychiatry. 1995;52:916–924. [PubMed: 7487340]

  • Caldwell MF, Vitacco M, Van-Rybroek GJ. Are violent delinquents worth treating? A cost-benefit analysis. Journal of Research in Crime and Delinquency. 2006;43:148–168.

  • Campbell FA, Ramey CT. Effects of early intervention on intellectual and academic achievement: a follow-up study of children from low-income families. Child Development. 1994;65:684–698. [PubMed: 8013248]

  • Campbell MA, French S, Gendreau P. Assessing the Utility of Risk Assessment Tools and Personality Measures in the Prediction of Violent Recidivism for Adult Offenders. User Report 2007–04. Ottawa, Canada: Department of Public Safety and Emergency Preparedness; 2007.

  • Cann J, Falshaw L, Nugent F, et al. Understanding What Works: Accredited Cognitive Skills Programmes for Adult Men and Young Offenders. Home Office Research Findings Number 226. London: Home Office; 2003.

  • Carr-Walker P, Bowers L, Callaghan P, et al. Attitudes towards personality disorders: comparison between prison officers and psychiatric nurses. Legal and Criminological Psychology. 2004;9:265–277.

  • Castillo H. Temperament or trauma? Users’ views on the nature and treatment of personality disorder. Mental Health Care. 2000;4:53–58.

  • Castillo H. Personality Disorder: Temperament of Trauma? An Account of an Emancipatory Research Study Carried Out by Service Users Diagnosed with Personality Disorder. London and Philadelphia: Jessica Kingsley; 2003.

  • Castillo H, Allen L, Coxhead N. The hurtfulness of a diagnosis: user research about personality disorder. Mental Health Practice. 2001;4:16–19.

  • Cavell TA, Hughes JN. Secondary prevention as a context for assessing change processes in aggressive children. Journal of School Psychology. 2000;38:199–235.

  • Chamberlain P, Reid JB. Comparison of two community alternatives to incarceration for chronic juvenile offenders. Journal of Consulting and Clinical Psychology. 1998;66:624–633. [PubMed: 9735578]

  • Chamberlain P, Leve LD, DeGarmo DS. Multidimensional foster care for girls in the juvenile justice system: 2 year follow up of a randomized clinical trial. Journal of Consulting and Clinical Psychology. 2007;75:187–193. [PMC free article: PMC1995088] [PubMed: 17295579]

  • Chevalier A, Feinstein L. Sheepskin or Prozac: the Causal Effect of Education on Mental Health. London: Centre for the Economics of Education; 2006.

  • Clark DH. The therapeutic community—concept, practice and future. British Journal of Psychiatry. 1965;111:947–954. [PubMed: 5833607]

  • Clark LA. Assessment and diagnosis of personality disorder: perennial issues and an emerging reconceptualization. Annual Review of Psychology. 2007;58:227–257. [PubMed: 16903806]

  • Clark LA, Livesley JW, Money L. Personality disorder assessment: the challenge of construct validity. Journal of Personality Disorders. 1997;11:205–231. [PubMed: 9348486]

  • Cleckley H. The Mask of Sanity. 1st edition. St. Louis: Mosby; 1941.

  • Coccaro EF, Kavoussi RJ. Fluoxetine and impulsive aggressive behaviour in personality-disordered subjects. Archives of General Psychiatry. 1997;54:1081–1088. [PubMed: 9400343]

    This is the reference for study ID COCCARO1997A.

  • Coccaro EF, Kavoussi RJ, Sheline YI, et al. Impulsive aggression in personality disorder correlates with tritiated paroxetine binding in the platelet. Archives of General Psychiatry. 1996;53:531–536. [PubMed: 8639036]

  • Coccaro EF, Berman ME, Kavoussi RJ, et al. Relationship of prolactin response to d-fenfluramine to behavioural and questionnaire assessments of aggression in personality disordered men. Biological Psychiatry. 1996;40:157–164. [PubMed: 8830948]

  • Cochrane Collaboration. Cochrane Handbook of Systematic Reviews. Oxford; Cochrane Collaboration: 2008.

  • Cohen M, Miller T. The cost of mental health care for victims of crime. Journal of Interpersonal Violence. 1998;13:93–110.

  • Cohen P, Crawford TN, Johnson JG, et al. The children in the community study of developmental course of personality disorders. Journal of Personality Disorders. 2005;19:466–486. [PubMed: 16274277]

  • Coid J. Epidemiology, public health and the problem of personality disorder. The British Journal of Psychiatry. 2003;182(Suppl 44):S3–S10. [PubMed: 12509301]

  • Coid J, Yang M, Tyrer P, et al. Prevalence and correlates of personality disorder in Great Britain. The British Journal of Psychiatry. 2006;188:423–431. [PubMed: 16648528]

  • Coid K, Yang M, Ullrich S, et al. Predicting and Understanding Risk of Re-offending: the Prisoner Cohort Study. London: Ministry of Justice; 2007.

  • Compton WM, Conway KP, Stinson FS, et al. Prevalence, correlates and comorbidity of DSM-IV antisocial personality syndromes and alcohol and specific drug use disorders in the United States: results from the National Epidemiological Survey on alcohol and related conditions. Journal of Clinical Psychiatry. 2005;66:677–685. [PubMed: 15960559]

  • Cooke DJ, Michie C. Refining the construct of psychopathy: toward a hierarchical model. Psychological Assessment. 2001;13:171–188. [PubMed: 11433793]

  • Cooke DJ, Michie C, Skeem J. Understanding the structure of the Psychopathy Checklist - Revised. The British Journal of Psychiatry. 2007;190:39–50. [PubMed: 17470942]

  • Conduct Problems Prevention Research Group. A developmental and clinical model for the prevention of conduct disorders: the FAST Track Program. Development and Psychopathology. 1992;4:509–527.

  • Connell S, Sanders M, Markie-Dadds C. Self-directed behavioral family intervention for parents of oppositional children in rural and remote areas. Behavior Modification. 1997;21:379–408. [PubMed: 9337598]

  • Copas J, Marshall M. The Offender Group Reconviction Scale: a statistical reconviction score for use by probation officers. Applied Statistics. 1998;47:159–171.

  • Cordess C, Cox M. Forensic Psychotherapy. London: Jessica Kingsley; 1998.

  • Cornelius JR, Soloff PH, Perel JM, et al. Fluoxetine trial in borderline personality disorder. Psychopharmacology Bulletin. 1990;26:151–154. [PubMed: 2371370]

  • Cote SM, Boivin M, Nagin DS, et al. The role of maternal education and nonmaternal care services in the prevention of children’s physical aggression problems. Archive of General Psychiatry. 2007;6:1305–1312. [PubMed: 17984399]

  • Cowdry RW, Gardner DL. Pharmacotherapy of borderline personality disorder: alprazolam, carbamazepine, trifluoperazine and tranylcypromine. Archives of General Psychiatry. 1989;45:111–119. [PubMed: 3276280]

  • Crane DR, Hillin HH, Jakubowski SF. Costs of treating conduct disordered Medicaid youth with and without family therapy. American Journal of Family Therapy. 2005;33:403–413.

  • Crawford M, Rutter D. Lessons learned from an evaluation of dedicated community-based services for people with personality disorder. Mental Health Review Journal. 2007;12:55–61.

  • Crawford M, Rutter D, Price K, et al. Learning the Lessons: a Multi-Method Evaluation Of Dedicated Community-Based Services for People with Personality Disorder. London: National Coordinating Centre for NHS Service Delivery and Organisation; 2007.

  • CSIP. Carers and Families of People with a Diagnosis of Personality Disorder: What Works: What is Needed: What is the Way Forward? 2006. [Accessed April 2008]. Available at: http://www​.personalitydisorder​.org.uk/assets/Resources/155​.pdf.

  • Curtis L. Unit Costs of Health and Social Care. 2007. [accessed June 2008]. Available at: http://www​.pssru.ac.uk/

  • Dadds MR, McHugh TA. Social support and treatment outcome in behavioral family therapy for child conduct problems. Journal of Consulting and Clinical Psychology. 1992;60:252–259. [PubMed: 1592955]

  • Dadds MR, Schwartz S, Sanders MR. Marital discord and treatment outcome in behavioral treatment of child conduct disorders. Journal of Consulting and Clinical Psychology. 1987;55:396–403. [PubMed: 3597955]

  • Dadds M, Sanders M, James J. The generalization of treatment effects in parent training with multidistressed parents. Behavioural Psychotherapy. 1987;15:314–318.

  • Dahle KP. Strengths and limitations of actuarial prediction of criminal reoffence in a German prison sample: a comparative study of LSI-R, HCR-20 and PCL-R. International Journal of Law and Psychiatry. 2006;29:431–442. [PubMed: 16780950]

  • Darke S, Sims J, McDonald S, et al. Cognitive impairment among methadone maintenance patients. Addiction. 2008;95:687–695. [PubMed: 10885043]

  • Davidson KM, Tyrer P, Tata P, et al. Cognitive behaviour therapy for violent men with antisocial personality disorder in the community: an exploratory randomized controlled trial. Psychological Medicine. 2008;38:1–9. [PubMed: 18667099]

  • De Brito S, Hodgins S. Antisocial personality disorder, Personality, Personality Disorder and Risk of Violence: An Evidence-Based Approach. McMurran M, Howard R, editors. Oxford: Wiley-Blackwell; 2009.

  • Deeks JJ. Issues in the selection of a summary statistic for meta-analysis of clinical trials with binary outcomes. Statistics in Medicine. 2002;21:1575–1600. [PubMed: 12111921]

  • Deffenbacher JL, Lynch RS, Oetting ER, et al. Anger reduction in early adolescents. Journal of Counseling Psychology. 1996;43:149–157.

  • Del Vecchio T, O’Leary D. Effectiveness of anger treatments for specific anger problems: meta-analytic review. Clinical Psychology Review. 2004;24:15–34. [PubMed: 14992805]

  • Dembo R, Ramirez-Garnica G, Rollie MW, et al. Youth recidivism twelve months after a family empowerment intervention: final report. Journal of Offender Rehabilitation. 2000;31:29–65.

  • Department of Health. Personality Disorder: No Longer a Diagnosis of Exclusion. Policy Implementation Guidance for the Development of Services for People with Personality Disorder. London: Department of Health; 2003.

  • Department of Health. Best Practice in Managing Risk: Principles and Evidence for Best Practice in the Assessment and Management of Risk to Self and Others in Mental Health Services. London: Department of Health; 2007.

  • Department of Health. Drug Misuse and Dependence: UK Guidelines on Clinical Management. London: Department of Health; 2007.

  • Department of Transport. Highways Economics Note No. 1. 2005 Valuation of the Benefits of Prevention of Road Accidents and Casualties. 2007. [accessed October 2008]. Available at: http://www​.dft.gov.uk.

  • DerSimonian R, Laird N. Meta-analysis in clinical trials. Controlled Clinical Trials. 1986;7:177–188. [PubMed: 3802833]

  • Desbiens N, Royer E. Peer groups and behaviour problems: a study of school-based intervention for children with EBD. Emotional and Behavioural Difficulties. 2003;8:120–139.

  • Dishion TJ, Andrews DW. Preventing escalation in problem behaviors with high-risk young adolescents: immediate and 1-year outcomes. Journal of Consulting and Clinical Psychology. 1995;63:538–548. [PubMed: 7673531]

  • Dodge KA. Conduct disorder, Handbook of Developmental Psychopathology. Sameroff A, Lewis M, Miller SM, editors. New York: Guilford; 2000. pp. 447–463.

  • Dolan B, Coid J. Psychopathic and Antisocial Personality Disorders: Treatment and Research Issues. London: Gaskell; 1993.

  • Dolan M, Doyle M. Violence risk prediction. The British Journal of Psychiatry. 2000;177:303–311. [PubMed: 11116770]

  • Dolan M, Anderson IM, Deakin JF. Relationship between 5-HT function and impulsivity and aggression in male offenders with personality disorders. The British Journal of Psychiatry. 2001;178:352–359. [PubMed: 11282815]

  • Dolan P, Moore S. From preferences to experiences: valuing the intangible victim costs of crime. International Review of Victimology. 2007;14:265–280.

  • Dolan P, Peasgood T. Estimating the economic and social costs of the fear of crime. British Journal of Criminology. 2007;47:121–132.

  • Dolan P, Loomes G, Peasgood T, et al. Estimating the intangible victim costs of violent crime. British Journal of Criminology. 2005;45:958–976.

  • Dolan P, Netten AP, Shapland J, et al. Towards a preference-based measure of the impact on well-being due to victimisation and the fear of crime. International Review of Victimology. 2007;14:253–264.

  • Dreessen L, Arntz A. The impact of personality disorders on treatment outcome of anxiety disorders: best-evidence synthesis. Behavior Research and Therapy. 1998;36:483–504. [PubMed: 9648326]

  • Dretzke J, Frew E, Davenport C, et al. The effectiveness and cost-effectiveness of parent training/education programmes for the treatment of conduct disorder, including oppositional defiant disorder, in children. Health Technology Assessment. 2005;9:1–233. [PubMed: 16336845]

  • Drugli MB, Larsson B. Children aged 4–8 years treated with parent training and child therapy because of conduct problems: generalisation effects to day-care and school settings. European Child and Adolescent Psychiatry. 2006;15:392–399. [PubMed: 16614786]

  • Drummond MF, Jefferson TO. Guidelines for authors and peer reviewers of economic submissions to the BMJ. British Medical Journal. 1996;313:275–283. [PMC free article: PMC2351717] [PubMed: 8704542]

  • Dubourg R, Hamed J. Estimates of the economic and social costs of crime in England and Wales: costs of crime against individuals and households, 2003/04, The Economic and Social Costs of Crime Against Individuals and Households 2003/04 Home Office, online report 30/05. 2005. [accessed October 2008]. Available at: http://www​.homeoffice​.gov.uk/rds/pdfs05/rdsolr3005.pdf.

  • Duff A. Psychopathy and moral understanding. American Philosophical Quarterly. 1977;14:189–200.

  • Dugan JR, Everett RS. An experimental test of chemical dependency therapy for jail inmates. International Journal of Offender Therapy and Comparative Criminology. 1998;42:360–368.

  • Duggan C. Developing services for people with personality disorder: the training needs of staff and services Unpublished manuscript. 2002

  • Duggan C. Why are programmes for offenders with personality disorder not informed by the relevant scientific findings? Philosophical Transactions of the Royal Society B: Biological Sciences. 2008;363:2483–2622. [PMC free article: PMC2606708] [PubMed: 18467278]

  • Duggan C, Adams C, McCarthy L, et al. Systematic review of the effectiveness of pharmacological and psychological strategies for the management of people with personality disorder, NHS National R&D Programme in Forensic Mental Health. 2007. [accessed March 2008]. Available at: http://www​.nfmhp.org​.uk/MRD%2012%2033%20Final%20Report.pdf.

    This review was updated and has been published as Duggan et al., 2007b and 2008.

  • Duggan C, Huband N, Smailagic N, et al. The use of psychological treatments for people with personality disorder: a systematic review of randomized controlled trials. Personality and Mental Health. 2007;1:95–125.

  • Duggan C, Huband N, Smailagic N, et al. The use of pharmacological treatments for people with personality disorder: a systematic review of randomized controlled trials. Personality and Mental Health. 2008;2:119–170.

  • Durlak JA. Successful Prevention Programs for Children and Adolescents. New York: Plenum Press; 1997.

  • Eccles M, Freemantle N, Mason J. North of England evidence based guideline development project: methods of developing guidelines for efficient drug use in primary care. British Medical Journal. 1998;316:1232–1235. [PMC free article: PMC1112989] [PubMed: 9553004]

  • Edens JF, Skeem JL, Douglas KS. Incremental validity analyses of the violence risk appraisal guide and the Psychopathy Checklist: Screening Version in a civil psychiatric sample. Assessment. 2006;13:368–374. [PubMed: 16880286]

  • Edmunson CB, Conger JC. A review of treatment efficacy for individuals with anger problems: conceptual, assessment and methodological issues. Clinical Psychology Review. 1996;16:251–275.

  • Elias LC, Dos Sontoas Marturano EM, De Almeida Motta AM, et al. Treating boys with low school achievement and behavior problems: comparison of two kinds of intervention. Psychological Reports. 2003;92:105–116. [PubMed: 12674267]

  • Elrod HP, Minor KI. Second wave evaluation of a multi-faceted intervention for juvenile court probationers. International Journal of Offender Therapy and Comparative Criminology. 1992;36:247–262.

  • ESMHCG. Personality Disorder Services Framework. 2005. [Accessed April 2008]. Available at: http://www​.personalitydisorder​.org.uk/assets/Resources/96​.pdf.

  • ESMHCG. East of England personality disorder capacity framework a year on Unpublished manuscript. 2006

  • Fallon P, Bluglass R, Edwards B. Ashworth Special Hospital: Report of the Committee of Inquiry. 1999. [accessed 23 April 2008]. Available at: http://www​.archive.official-documents​.co​.uk/document/cm41/4194/ash-00.htm.

  • Faraone SV, Biederman J, Jetton JG, et al. Attention deficit disorder and conduct disorder: longitudinal evidence for a familial subtype. Psychological Medicine. 1997;27:291–300. [PubMed: 9089822]

  • Farmer TW, Price LN, O’Neal KK, et al. Exploring risk in early adolescent African American youth. American Journal of Community Psychology. 2004;33:51–59. [PubMed: 15055754]

  • Farrington DP. Early predictors of adolescent aggression and adult violence. Violence and Victims. 1989;4:79–100. [PubMed: 2487131]

  • Farrington DP, Coid JW. Early Prevention of Adult Antisocial Behaviour, Cambridge Studies in Criminology. Cambridge: Cambridge University Press; 2003.

  • Farrington DP, Welsh BC. A half-century of randomized experiments on crime and justice, Crime and Justice. Tonry M, editor. Vol. 34. Chicago: University of Chicago Press; 2006. pp. 55–132.

  • Farrington DP, Ohlin LE, Wilson JQ. Understanding and Controlling Crime: Toward a New Research Strategy. New York: Springer-Verlag; 1986.

  • Faulkner A, Morris B. User Involvement in Forensic Mental Health Research and Development. Liverpool: NHS National Programme on Forensic Mental Research and Development; 2002.

  • Fazel S, Danesh J. Serious mental disorder in 23,000 prisoners: a systematic review of 62 surveys. Lancet. 2002;359:545–550. [PubMed: 11867106]

  • Feindler EL, Marriott SA, Iwata M. Group anger control training for junior high school delinquents. Cognitive Therapy and Research. 1984;8:299–311.

  • Feinfield KA, Baker BL. Empirical support for a treatment program for families of young children with externalizing problems. Journal of Clinical Child and Adolescent Psychology. 2004;33:182–195. [PubMed: 15028552]

  • Ferguson B, Tyrer R. History of the concept of personality disorder, Personality Disorders: Diagnosis, Management and Course. Tyrer P, editor. Oxford: Butterworth-Heinemann; 2000.

  • Fergusson DM, Horwood JL, Lynskey MT. The childhoods of multiple problem adolescents: a 15 year longitudinal study. Journal of Child Psychology and Psychiatry. 1994;32:1123–1140. [PubMed: 7995847]

  • Fonagy P, Target M, Cottrell D, et al. What Works for Whom: A Critical Review of Treatments for Children and Adolescents. New York: Guilford; 2002.

  • Foster EM, Jones DE. the Conduct Problems Prevention Research Group. The high costs of aggression: public expenditures resulting from conduct disorder. American Journal of Public Health. 2005;95:1767–1772. [PMC free article: PMC1449434] [PubMed: 16131639]

  • Foster EM, Jones D, Bierman KL, et al. Can a costly intervention be cost-effective? An analysis of violence prevention. Archives of General Psychiatry. 2006;63:1284–1291. [PMC free article: PMC2753445] [PubMed: 17088509]

  • Fournier JC, DeRubeis RJ, Shelton RC, et al. Antidepressant medications v. cognitive therapy in people with depression with or without personality disorder. The British Journal of Psychiatry. 2008;192:124–129. [PMC free article: PMC2682552] [PubMed: 18245030]

  • Fraser M, Day S, Galinsky M, et al. Conduct problems and peer rejection in childhood: a randomized trial of the Making Choices and Strong Families programs. Research on Social Work Practice. 2004;14:313–324.

  • Friendship C, Blud L, Erikson M, et al. An Evaluation of Cognitive Behavioural Treatment for Prisoners. Home Office Research Report Findings 161. London: Home Office; 2002.

  • Fulford KWM, Thornton T, Graham G. The Oxford Textbook of Philosophy and Psychiatry. Oxford: Oxford University Press; 2006.

  • Furukawa TA, Barbui C, Cipriani A, et al. Imputing missing standard deviations in meta-analyses can provide accurate results. Journal of Clinical Epidemiology. 2006;59:7–10. [PubMed: 16360555]

  • Galen LW, Brower KJ, Gillespie BW, et al. Sociopathy, gender, and treatment outcome among outpatient substance abusers. Drug and Alcohol Dependence. 2000;61:23–33. [PubMed: 11064181]

  • Gardner F, Burton J, Kilimes I. Randomised controlled trial of a parenting intervention in the voluntary sector for reducing child conduct problems: outcomes and mechanisms of change. Journal of Child Psychology and Psychiatry. 2006;47:1123–1132. [PubMed: 17076751]

  • Gelhorn HJ, Sakai JT, Price RK, et al. DSM-IV conduct disorder criteria as predictors of antisocial personality disorder. Comprehensive Psychiatry. 2007;48:529–538. [PMC free article: PMC2764329] [PubMed: 17954138]

  • General Medical Council. Good Medical Practice. London: General Medical Council; 2006.

  • Godfrey C, Eaton G, McDougall C, et al. The Economic and Social Costs of Class A Drug Use in England and Wales. Home Office Research Study 249. London: Home Office; 2002.

  • Goldberg SC, Schulz SC, Schulz PM, et al. Borderline and schizotypal personality disorders treated with low-dose thiothixene vs. placebo. Archives of General Psychiatry. 1986;43:680–686. [PubMed: 3521531]

  • Goodwin R, Hamilton SP. Lifetime comorbidity of antisocial personality disorder and anxiety disorders among adults in the community. Psychiatry Research. 2003;117:159–166. [PubMed: 12606017]

  • Gordon DA, Graves K, Arbuthnot J. The effect of functional family therapy for delinquents on adult criminal behavior. Criminal Justice and Behavior. 1995;22:60–73.

  • Gordon R. An operational classification of disease prevention. Public Health Reports. 1983;98:107–109. [PMC free article: PMC1424415] [PubMed: 6856733]

  • Gordon RA. A critique of the evaluation of Patuxent Institution, with particular attention to the issues of dangerousness and recidivism. Bulletin of the American Academy of Psychiatry and the Law. 1977;5:210–255. [PubMed: 588753]

  • Gottschalk LA, Covi L, Uliana R. Effects of diphenylhydantoin on anxiety and hostility in institutionalized prisoners. Comprehensive Psychiatry. 1973;14:503–511. [PubMed: 4587507]

  • GRADE Working Group. Grading quality of evidence and strength of recommendations. British Medical Journal. 2004;328:1490–1497. [PMC free article: PMC428525] [PubMed: 15205295]

  • Grann M, Langstrom N, Tengstrom A, et al. Psychopathy (PCL-R) predicts violent recidivism among criminal offenders with personality disorders in Sweden. Law and Human Behavior. 1999;23:205–217. [PubMed: 10333757]

  • Grann M, Belfrage H, Tengstrom A. Actuarial assessment of risk for violence: predictive validity of the VRAG and the historical part of the HCR-20. Criminal Justice and Behavior. 2000;27:97–114.

  • Greenwood GL, Woods WJ, Guydish J, et al. Relapse outcomes in a randomised trial of residential and day drug abuse treatment. Journal of Substance Abuse Treatment. 2001;20:15–23. [PubMed: 11239724]

  • Greenwood PW, Turner S. Evaluation of the Paint Creek Youth Center: a residential program for serious delinquents. Criminology. 1993;31:263–279.

  • Grilo CM, McGlashan TH, Oldham JM. Course and stability of personality disorders. Journal of Practical Psychiatry and Behavioural Health. 1998;4:61–75.

  • Griffith JD, Hiller ML, Knight K, et al. A cost-effectiveness analysis of in-prison therapeutic community treatment and risk classification. The Prison Journal. 1999;79:352–368.

  • Guerra NG, Slaby RG. Cognitive mediators of aggression in adolescent offenders: 2. intervention. Developmental Psychology. 1990;26:269–277.

  • Gunderson JG, Frank AF, Ronningstam EF, et al. Early discontinuance of borderline patients from psychotherapy. Journal of Nervous and Mental Disease. 1989;177:38–42. [PubMed: 2909661]

  • Guze S. Criminality and Psychiatric Disorders. New York: Oxford University Press; 1976.

  • Haddock A, Snowden P, Dolan M, et al. Managing dangerous people with severe personality disorder: a survey of forensic psychiatrists’ opinions. Psychiatric Bulletin. 2001;25:293–296.

  • Haigh R. Services for people with personality disorder: the thoughts of service users. 2002. [accessed 10 April 2008]. Available at: http://www​.dh.gov.uk​/en/Publicationsandstatistics​/Publications​/PublicationsPolicyAndGuidance​/DH_4009546.

  • Hanson R, Thornton D. Static 99: Improving Actuarial Risk Assessments for Sex Offenders. Canada: Public Works and Government Services Canada; 1999.

  • Hare RD. A research scale for the assessment of psychopathy in criminal populations. Personality and Individual Differences. 1980;1:111–117.

  • Hare RD. The Hare Psychopathy Checklist-Revised (PCL-R). Toronto: Multi-Health Systems; 1991.

  • Hare RD, Hart SD, Harpur TJ. Psychopathy and the DSM-IV criteria for antisocial personality disorder. Journal of Abnormal Psychology. 1991;100:391–398. [PubMed: 1918618]

  • Hare RD, Clark D, Grann M, et al. Psychopathy and the predictive validity of the PCL-R: an international perspective. Behavioral Sciences and the Law. 2000;18:623–645. [PubMed: 11113965]

  • Harris GT, Rice ME, Cormier CA. Psychopathy and violent recidivism. Law and Human Behavior. 1991;15:625–637.

  • Harris GT, Rice ME, Quinsey VL. A multisite comparison of actuarial risk instruments for sex offenders. Psychological Assessment. 2003;15:413–425. [PubMed: 14593842]

  • Harrison T. Advancing on a Different Front. London: Jessica Kingsley; 2002.

  • Hart SD. Psychopathy and risk for violence, Psychopathy: Theory, Research and Implications for Society. Cooke DE, Forth A, Hare RD, editors. Dordrecht, Netherlands: Kluwer; 1998. pp. 355–373.

  • Hart SD. The role of psychopathy in assessing risk for violence: conceptual and methodological issues. Legal and Criminological Psychiatry. 1998;3:121–137.

  • Hart SD, Hare RD. Discriminant validity of the Psychopathy Checklist in a forensic psychiatric population. Psychological Assessment. 1989;1:211–218.

  • Hart SD, Cox DN, Hare RD. The Hare Psychopathy Checklist Screening Version (PCL:SV). Toronto, Canada: Multi-Health Systems; 1999.

  • Hart SD, Michie C, Cooke DJ. Precision of actuarial risk assessment instruments: evaluating the ‘margins of error’ of group v individual predictions of violence. British Journal of Psychiatry. 2007;190:60–65. [PubMed: 17470944]

  • Hawkins JD, Von Cleve E, Catalano RF. Reducing early childhood aggression: results of a primary prevention programme. Journal of the American Academy of Child and Adolescent Psychiatry. 1991;30:208–217. [PubMed: 2016224]

  • Hawkins JD, Catalano RF, Morrison DM, et al. The Seattle Social Development Project: effects of the first four years on protective factors and problem behaviours, Preventing Antisocial Behaviour: Interventions from Birth through Adolescence. McCord J, Tremblay RE, editors. New York: Guilford Press; 1992. pp. 139–161.

  • Hawkins JD, Catalano RF, Brewer DD. Preventing serious, violent, and chronic juvenile offending: effective strategies from conception to age 6, Source Book on Serious Violent, and Chronic Juvenile Offenders. Howell JC, Krisberg B, Hawkins JD, et al., editors. Thousand Oaks, CA: Sage; 1995. pp. 47–60.

  • Hawkins JD, Catalano RF, Kosterman R, et al. Preventing adolescent health-risk behaviors by strengthening protection during childhood. Archives of Pediatrics and Adolescent Medicine. 1999;153:226–234. [PubMed: 10086398]

  • Hawkins JD, Kosterman R, Catalano RF, et al. Promoting positive adult functioning through social development intervention in childhood: long-term effects from the Seattle Social Development Project. Archives of Pediatrics and Adolescent Medicine. 2005;159:25–31. [PubMed: 15630054]

  • Helgeland MI, Kjelsberg E, Torgersen S. Continuities between emotional and disruptive behavior disorders in adolescence and personality disorders in adulthood. American Journal of Psychiatry. 2005;10:1941–1947. [PubMed: 16199842]

  • Henderson DK. Psychopathic States. New York: Norson; 1939.

  • Henggeler SW, Melton GB, Smith LA. Family preservation using multisystemic therapy: an effective alternative to incarcerating serious juvenile offenders. Journal of Consulting and Clinical Psychology. 1992;60:953–961. [PubMed: 1460157]

  • Henggeler SW, Melton GB, Brondino MJ, et al. Multisystemic therapy with violent and chronic juvenile offenders and their families: the role of treatment fidelity in successful dissemination. Journal of Consulting and Clinical Psychology. 1997;65:821–833. [PubMed: 9337501]

  • Henggeler SW, Pickrel SG, Brondino MJ. Multisystemic treatment of substance-abusing and -dependent delinquents: outcomes, treatment fidelity, and transportability. Mental Health Services Research. 1999;1:171–184. [PubMed: 11258740]

  • Henggeler SW, Halliday-Boykins CA, Cunningham PB, et al. Juvenile drug court: enhancing outcomes by integrating evidence-based treatments. Journal of Consulting and Clinical Psychology. 2006;74:42–54. [PubMed: 16551142]

  • Henggeler SW, Schoenwald SK, Swenson CC, et al. Methodological critique and meta-analysis as Trojan horse. Children and Youth Services Review. 2006;28:447–457.

  • Herrenkohl TI, Maguin E, Hill KG, et al. Developmental risk factors for youth violence. Journal of Adolescent Health. 2000;26:176–186. [PubMed: 10706165]

  • Hesselbrock M. Gender comparison of antisocial personality disorder and depression in alcoholism. Journal of Substance Abuse. 1991;3:205–219. [PubMed: 1668227]

  • Higgins JPT, Thompson SG. Quantifying heterogeneity in a meta-analysis. Statistics in Medicine. 2002;21:1539–1558. [PubMed: 12111919]

  • Hill J. Early identification of individuals at risk for antisocial personality disorder. British Journal of Psychiatry. 2003;182:S11–S14. [PubMed: 12509302]

  • HM Inspectorate of Prisons. The Mental Health of Prisoners: a Thematic Review of the Care and Support of Prisoners with Mental Health Needs. London: HM Inspectorate of Prisons; 2007.

  • HMSO. Mental Health Act 1959. London: The Stationery Office; 1959. [Accessed October 2008]. Available at: http://www​.opsi.gov.uk​/RevisedStatutes/Acts​/ukpga/1959/cukpga_19590072_en_1.

  • HMSO. Criminal Justice Act 2003. London: The Stationery Office; 2003. [Accessed October 2008]. Available at: http://www​.opsi.gov.uk​/acts/acts2003/ukpga_20030044_en_1.

  • HMSO. The Mental Capacity Act 2005. London: The Stationery Office; 2005. [Accessed October 2008]. Available at: http://www​.opsi.gov.uk​/acts/acts2005/ukpga_20050009_en_1.

  • HMSO. The Mental Health Act 2007. London: The Stationery Office; 2007. [Accessed October 2008]. Available at: http://www​.opsi.gov.uk​/acts/acts2007/ukpga_20070012_en_1.

  • Hollander E, Stein DJ, DeCaria CM, et al. Serotonergic sensitivity in borderline personality disorder: preliminary findings. American Journal of Psychiatry. 1994;151:277–280. [PubMed: 8296905]

  • Hollander E, Tracy KA, Swann AC, et al. Divalproex in the treatment of impulsive aggression: efficacy in cluster B personality disorders. Neuropsychopharmacology. 2003;28:1186–1197. [PubMed: 12700713]

  • Hollin CR. Treatment programs for offenders. Meta-analysis, ‘what works,’ and beyond. International Journal of Law and Psychiatry. 1999;22:361–372. [PubMed: 10457930]

  • Home Office. Managing dangerous people with personality disorder: proposals for policy development. 1997. [Accessed July 2008]. Available at: http://www​.homeoffice​.gov.uk/documents/cons-1999-personality-disorder?view​=Binary.

  • Home Office. Dangerous and Severe Personality Disorder (DSPD) High Secure Services For Men: Planning and Delivery Guide. 2005. [Accessed April 2008]. Available at: http://www​.dspdprogramme​.gov.uk/media/pdfs​/High_Secure_Services_for_Men.pdf.

  • Home Office. Forensic Personality Disorder Medium Secure and Community Pilot Services: Planning and Delivery Guide.

  • One thought on “Gil Brewer Bibliography Apa

    Leave a Reply

    Your email address will not be published. Required fields are marked *